医学
临床试验
数据收集
食品药品监督管理局
冲程(发动机)
可解释性
替代医学
临床研究设计
临床研究
综合数据
研究设计
医学物理学
重症监护医学
梅德林
风险分析(工程)
病理
人工智能
计算机科学
机械工程
数学
社会科学
法学
政治学
社会学
统计
工程类
作者
Karen A. Hicks,Kenneth W. Mahaffey,Roxana Mehran,Steven E. Nissen,Stephen D. Wiviott,Billy Dunn,Scott David Solomon,John R. Marler,John R. Teerlink,Andrew A. Farb,David A. Morrow,Shari L. Targum,Cathy A. Sila,Mary Thanh Hai,Michael R. Jaff,Hylton V. Joffe,Donald E. Cutlip,Akshay Suvas Desai,Eldrin Foster Lewis,Charles Michael Gibson
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2018-02-26
卷期号:137 (9): 961-972
被引量:822
标识
DOI:10.1161/circulationaha.117.033502
摘要
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the U.S. Food and Drug Administration (FDA). The FDA established the Standardized Data Collection for Cardiovascular Trials Initiative in 2009 to simplify the design and conduct of clinical trials intended to support marketing applications. The writing committee recognizes that these definitions may be used in other types of clinical trials and clinical care processes where appropriate. Use of these definitions at the FDA has enhanced the ability to aggregate data within and across medical product development programs, conduct meta-analyses to evaluate cardiovascular safety, integrate data from multiple trials, and compare effectiveness of drugs and devices. Further study is needed to determine whether prospective data collection using these common definitions improves the design, conduct, and interpretability of the results of clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI